Literature DB >> 9497861

Gaucher's Disease. Pathological features.

G M Pastores1.   

Abstract

Gaucher's disease is the most common lysosomal storage disease. The pathological features are a consequence of the progressive accumulation of glucosylceramide within mononuclear phagocytes. A wide variety of gross and microscopic anatomical changes are seen, primarily in the bone marrow, liver, spleen and bones. It is probable that cellular reactions to the presence of Gaucher cells ('lipid-engorged' macrophages) contribute to the tissue damage observed in this disease, although only a few investigations have been undertaken to elucidate what, if any, other mechanisms may play a contributory role in defining individual disease outcome. The general clinico-pathological features of Gaucher's disease are reviewed herein, with exclusion of the central nervous system and skin involvement, which are covered elsewhere.

Entities:  

Mesh:

Year:  1997        PMID: 9497861     DOI: 10.1016/s0950-3536(97)80037-6

Source DB:  PubMed          Journal:  Baillieres Clin Haematol        ISSN: 0950-3536


  10 in total

Review 1.  GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies.

Authors:  Parker H Johnson; Neal J Weinreb; James C Cloyd; Paul J Tuite; Reena V Kartha
Journal:  Mol Genet Metab       Date:  2019-10-23       Impact factor: 4.797

Review 2.  The pathophysiology of GD - current understanding and rationale for existing and emerging therapeutic approaches.

Authors:  Derralynn A Hughes; Gregory M Pastores
Journal:  Wien Med Wochenschr       Date:  2010-12

Review 3.  Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.

Authors:  Hagit N Baris; Ian J Cohen; Pramod K Mistry
Journal:  Pediatr Endocrinol Rev       Date:  2014-09

4.  Pseudo-Gaucher cells in myelodysplasia.

Authors:  A J Stewart; R D Jones
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

5.  Identification of a feedback loop involving β-glucosidase 2 and its product sphingosine sheds light on the molecular mechanisms in Gaucher disease.

Authors:  Sophie Schonauer; Heinz G Körschen; Anke Penno; Andreas Rennhack; Bernadette Breiden; Konrad Sandhoff; Katharina Gutbrod; Peter Dörmann; Diana N Raju; Per Haberkant; Mathias J Gerl; Britta Brügger; Hila Zigdon; Ayelet Vardi; Anthony H Futerman; Christoph Thiele; Dagmar Wachten
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

Review 6.  'Fly-ing' from rare to common neurodegenerative disease mechanisms.

Authors:  Mengqi Ma; Matthew J Moulton; Shenzhao Lu; Hugo J Bellen
Journal:  Trends Genet       Date:  2022-04-25       Impact factor: 11.821

7.  A model of neuronopathic Gaucher disease.

Authors:  P E Campbell; C M Harris; C M Harris; T Sirimanna; A Vellodi
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

8.  Aberrant receptor-mediated endocytosis of Schistosoma mansoni glycoproteins on host lipoproteins.

Authors:  Hein Sprong; Monika Suchanek; Suzanne M van Dijk; Alexandra van Remoortere; Judith Klumperman; Diana Avram; Joke van der Linden; Jeanette H W Leusen; Jaap J van Hellemond; Christoph Thiele
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

9.  Hemorrhagic aspects of Gaucher disease.

Authors:  Hanna Rosenbaum
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

10.  CRISPR/Cas9 Editing for Gaucher Disease Modelling.

Authors:  Eleonora Pavan; Maximiliano Ormazabal; Paolo Peruzzo; Emilio Vaena; Paula Rozenfeld; Andrea Dardis
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.